The IPKat
MAY 20, 2024
In this webinar, Sir Robin and Dheemanth will explore the requirement’s origins, how it has been applied by EPO and the English courts in recent years, and what they envisage for the requirement’s future. Webinar - The "Taylor’s Version Strategy" or re-recording music albums: (legally) possible in EU too? (13
LexBlog IP
JANUARY 31, 2024
We presented a webinar last week entitled How to Win Your Next Trademark Battle: Lessons Learned in 2023 to give brand owners and their lawyers an overview of key takeaways from last year’s trademark cases. misuse of their trademarks when drafting license or distribution agreements with non-U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trademark and Copyright Law Blog
APRIL 13, 2021
Your company has invested in developing its goodwill and protecting its brands, and now seeks to bring in partners. Or perhaps your company seeks to grow by on-boarding third-party brands. Co-branding agreements. Learn the essentials for successful brand protection in the context of business deals. Bankruptcy.
SpicyIP
OCTOBER 31, 2023
Image from here Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“ CL ”) for breast cancer medications, Ribociclib and Abemaciclib. It also says that no licenses were given out. – It imposes a burden of 17.7 million disability-adjusted life years (DALYs).
The IPKat
MAY 5, 2024
The Webinar will feature current program students presenting their latest articles on cutting-edge IP topics, as published in the Journal of Intellectual Property Law and Practice and The IPKat. Register to attend here. Visit here to register and take a look at the agenda.
The IPKat
JUNE 26, 2022
Marques - CELEBRATING MARKS: How sustainability and technology will shape the future of brands - 20 to 23 September 2022 - Madrid, Spain The 2022 MARQUES Annual Conference will be held in Madrid from 20 to 23 September 2022. The webinar is scheduled for 7 July 2022 from 3:00pm to 5:00pm (CEST) and would be open to SMEs from the U.S.
The IP Law Blog
AUGUST 12, 2021
For example, and this is the most prevalent issue I’ve seen, many companies include language in the agreements that would grant the company a license “in perpetuity” to use the athlete’s NIL. If the player and/or the company do not have a license from the school or the sponsor to use those marks, that too is infringement.
Expert insights. Personalized for you.
61 
Let's personalize your content